Study of the prevalence of shivering after spinal anesthesia in patients undergoing cesarean section receiving misoprostol

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20250101064235N1

Enrollment

502

Registered

2025-01-06

Start date

2025-01-09

Completion date

Unknown

Last updated

2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Shivering. Other complications of anaesthesia

Interventions

Intervention 1: Intervention group: This group receives 200 mg of misoprostol (Cytotec) before surgery. Intervention 2: Control group: They do not receive medication.

Eligibility

Sex/Gender

Female

Age

18 Years to 45 Years

Inclusion criteria

Inclusion criteria: Age 18-45 years Candidate for cesarean section

Exclusion criteria

Exclusion criteria: The operation lasts more than 4 hours. Hemodynamic disturbances

Design outcomes

Primary

Measure	Time frame
Shivering. Timepoint: After the surgery is over. Method of measurement: Observation and examination.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarzaneh Ghadbegi

Islamic Azad University

Farzaneh.ghadbeygi@gmail.com+98 21 2660 2642

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026